Company: ADZCF
Filing Date: 2025-10-31
Form Type: 424B2
Source: 0000950103-25-014057
Chunk: 7

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-10-31
Form: 424B2
Chunk 7
---
of the Securities and Exchange Commission (the “SEC”) at.www.sec.gov as follows (or,
if such address has changed, by reviewing our filings for the relevant date on the SEC website):

https://www.sec.gov/Archives/edgar/data/1159508/000095010324005869/crt_dp210214-424b2.pdf

https://www.sec.gov/Archives/edgar/data/1159508/000095010324005867/crt_dp210215-424b2.pdf

https://www.sec.gov/Archives/edgar/data/1159508/000095010324005861/crt_dp210217-424b2.pdf

https://www.sec.gov/Archives/edgar/data/1159508/000119312524118649/d776815d424b21.pdf

Our Central Index Key,
or CIK, on the SEC website is 0001159508. As used in this pricing supplement, “we,” “us” or “our”
refers to Deutsche Bank AG, including, as the context requires, acting through one of its branches.

This pricing supplement,
together with the documents listed above, contains the terms of the Securities and supersedes all other prior or contemporaneous oral
statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures
for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things,
the matters set forth in this pricing supplement and in “Risk Factors” in the accompanying product supplement, prospectus
supplement and prospectus, as the Securities involve risks not associated with conventional debt securities. We urge you to consult your
investment, legal, tax, accounting and other advisors before deciding to invest in the Securities.

You may revoke your offer to purchase the Securities at any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the terms of, or reject any offer to purchase, the Securities prior to their issuance. We will notify you in the event of any changes to the terms of the Securities and you will be asked to accept such changes in connection with your purchase of any Securities. You may choose to reject such changes, in which case we may reject your offer to purchase the Securities.

<div align='center'>PS-4</div>

| Investor Suitability |

The Securities may be appropriate for you if:

| ¨ | You fully